TITLE

Regulatory Roles of Non-Coding RNAs in Colorectal Cancer

AUTHOR(S)
Jun Wang; Yong-Xi Song; Bin Ma; Jia-Jun Wang; Jing-Xu Sun; Xiao-Wan Chen; Jun-Hua Zhao; Yu-Chong Yang; Zhen-Ning Wang
PUB. DATE
August 2015
SOURCE
International Journal of Molecular Sciences;Aug2015, Vol. 16 Issue 8, p19886
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Non-coding RNAs (ncRNAs) have recently gained attention because of their involvement in different biological processes. An increasing number of studies have demonstrated that mutations or abnormal expression of ncRNAs are closely associated with various diseases including cancer. The present review is a comprehensive examination of the aberrant regulation of ncRNAs in colorectal cancer (CRC) and a summary of the current findings on ncRNAs, including long ncRNAs, microRNAs, small interfering RNAs, small nucleolar RNAs, small nuclear RNAs, Piwi-interacting RNAs, and circular RNAs. These ncRNAs might become novel biomarkers and targets as well as potential therapeutic tools for the treatment of CRC in the near future and this review may provide important clues for further research on CRC and for the selection of effective therapeutic targets.
ACCESSION #
109123264

 

Related Articles

  • Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Xiang, Jian-Feng; Yin, Qing-Fei; Chen, Tian; Zhang, Yang; Zhang, Xiao-Ou; Wu, Zheng; Zhang, Shaofeng; Wang, Hai-Bin; Ge, Junhui; Lu, Xuhua; Yang, Li; Chen, Ling-Ling // Cell Research;Sep2014, Vol. 24 Issue 9, p1150 

    A correction to the article "Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus" that was published in a 2014 issue is presented.

  • Achieving high-sensitivity for clinical applications using augmented exome sequencing. Patwardhan, Anil; Harris, Jason; Nan Leng; Bartha, Gabor; Church, Deanna M.; Shujun Luo; Haudenschild, Christian; Pratt, Mark; Zook, Justin; Salit, Marc; Tirch, Jeanie; Massimo Morra; Chervitz, Stephen; Ming Li; Clark, Michael; Garcia, Sarah; Chandratillake, Gemma; Kirk, Scott; Ashley, Euan; Snyder, Michael // Genome Medicine;Aug2015, Vol. 7 Issue 1, p1 

    Background: Whole exome sequencing is increasingly used for the clinical evaluation of genetic disease, yet the variation of coverage and sensitivity over medically relevant parts of the genome remains poorly understood. Several sequencing-based assays continue to provide coverage that is...

  • Use of semantic workflows to enhance transparency and reproducibility in clinical omics. Zheng, Christina L.; Ratnakar, Varun; Gil, Yolanda; McWeeney, Shannon K. // Genome Medicine;Aug2015, Vol. 7 Issue 1, p1 

    Background: Recent highly publicized cases of premature patient assignment into clinical trials, resulting from non-reproducible omics analyses, have prompted many to call for a more thorough examination of translational omics and highlighted the critical need for transparency and...

  • Junk DNA is not really junk afterall ...  // BioSpectrum;Jan2013, Vol. 11 Issue 1, p89 

    The article focuses on noncoding DNA sequences of an organism. It mentions that noncoding DNA are DNA components that could not encode protein sequences, in which they were adapted into functional noncoding RNA molecules. Furthermore, it says that noncoding DNA in genome is about 98 percent, and...

  • A Statistical Framework to Predict Functional Non-Coding Regions in the Human Genome Through Integrated Analysis of Annotation Data. Lu, Qiongshi; Hu, Yiming; Sun, Jiehuan; Cheng, Yuwei; Cheung, Kei-Hoi; Zhao, Hongyu // Scientific Reports;5/29/2015, p10576 

    Identifying functional regions in the human genome is a major goal in human genetics. Great efforts have been made to functionally annotate the human genome either through computational predictions, such as genomic conservation, or high-throughput experiments, such as the ENCODE project. These...

  • A Human Long Non-Coding RNA ALT1 Controls the Cell Cycle of Vascular Endothelial Cells Via ACE2 and Cyclin D1 Pathway. Li, Wen; Wang, Rui; Ma, Jie-yi; Wang, Mian; Cui, Jin; Wu, Wei-bin; Liu, Rui-ming; Zhang, Chun-xiang; Wang, Shen-ming // Cellular Physiology & Biochemistry (Karger AG);Nov2017, Vol. 43 Issue 3, p1152 

    Background/Aims: ALT1 is a novel long non-coding RNA derived from the alternatively spliced transcript of the deleted in lymphocytic leukemia 2 (DLEU2). To date, ALT1 biological roles in human vascular endothelial cells have not been reported. Methods: ALT1 was knocked down by siRNAs. Cell...

  • Long non-coding RNA NKILA serves as a biomarker in the early diagnosis and prognosis of patients with colorectal cancer. Jiang, Peng; Han, Xiaoting; Zheng, Yingnan; Sui, Jianchao; Bi, Weiping // Oncology Letters;Aug2019, Vol. 18 Issue 2, p2109 

    Colorectal cancer (CRC) is one of the leading causes of cancer-associated mortality worldwide. The prognosis of patients with CRC at an advanced stage is poor. Biomarkers currently used in clinical practice, including carcinoembryonic antigen (CEA) and cancer antigen (CA) 19-9, lack sufficient...

  • Junk DNA and the long non-coding RNA twist in cancer genetics. Ling, H; Vincent, K; Pichler, M; Fodde, R; Berindan-Neagoe, I; Slack, F J; Calin, G A // Oncogene;9/24/2015, Vol. 34 Issue 39, p5003 

    The central dogma of molecular biology states that the flow of genetic information moves from DNA to RNA to protein. However, in the last decade this dogma has been challenged by new findings on non-coding RNAs (ncRNAs) such as microRNAs (miRNAs). More recently, long non-coding RNAs (lncRNAs)...

  • An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Shihab, Hashem A.; Rogers, Mark F.; Gough, Julian; Mort, Matthew; Cooper, David N.; Day, Ian N. M.; Gaunt, Tom R.; Campbell, Colin // Bioinformatics;5/15/2015, Vol. 31 Issue 10, p1536 

    Motivation: Technological advances have enabled the identification of an increasingly large spectrum of single nucleotide variants within the human genome, many of which may be associated with monogenic disease or complex traits. Here, we propose an integrative approach, named FATHMM-MKL, to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics